In this context, B-cell lymphoma 2 (BCL-2) family proteins, notably myeloid cell leukemia-1 (MCL-1), are known for their role in both the development and persistence of AML [6, 7], and are often associated with cancer-cell survival and resistance to chemotherapy [8, 9]. This evidence concerns the gene BCL2 and acute myeloid leukemia.